2XY9 - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE

Authors :   M. Akif, S. L. Schwager, C. S. Anthony, B. Czarny, F. Beau, V. Dive, E. D. S K. R. Acharya

Date :   16 Nov 10 (Deposition) - 11 May 11 (Release) - 11 Apr 12 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.97

Chains :   Asym./Biol. Unit : A

Keywords :   Hydrolase, Zinc Metalloprotease, Metallopeptidase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   M. Akif, S. L. Schwager, C. S. Anthony, B. Czarny, F. Beau, V. Dive, E. D. Sturrock, K. R. Acharya
Novel Mechanism Of Inhibition Of Human Angiotensin- I-Converting Enzyme (Ace) By A Highly Specific Phosphinic Tripeptide.
Biochem. J. V. 436 53 2011
PubMed-ID: 21352096 | Reference-DOI: 10.1042/BJ20102123

Molecule 1 - ANGIOTENSIN-CONVERTING ENZYME
	Chains	:	A
	EC Number	:	3.4.15.1
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Cell Line	:	CHINESE HAMSTER OVARY CELLS
	Expression System Common	:	CHINESE HAMSTER
	Expression System Plasmid	:	PLEN/PEE14
	Expression System Taxid	:	10029
	Expression System Vector Type	:	PLASMID
	Fragment	:	RESIDUES 71-654
	Organ	:	TESTIS
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ACE, DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II, CD143

		1
Asymmetric/Biological Unit	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (8, 12)

No.	Name	Count	Type	Full Name
1	3ES	2	Ligand/Ion	[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY)[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]-AMINO}ETHYL)PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL)METHYL]-1-OXO-PROPYL}AMINO)-3-(4-HYDROXY-PHENYL)
2	ACT	1	Ligand/Ion	ACETATE ION
3	BMA	1	Ligand/Ion	BETA-D-MANNOSE
4	CL	2	Ligand/Ion	CHLORIDE ION
5	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID
6	FUC	1	Ligand/Ion	ALPHA-L-FUCOSE
7	NAG	3	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
8	ZN	1	Ligand/Ion	ZINC ION

Asymmetric Unit (8, 8)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	ASP A:121 , GLU A:123 , ALA A:208 , ASN A:211 , SER A:219 , HOH A:2421 , HOH A:2422	BINDING SITE FOR RESIDUE ACT A1625
2	AC2	SOFTWARE	ARG A:186 , TRP A:485 , TRP A:486 , ARG A:489	BINDING SITE FOR RESIDUE CL A1626
3	AC3	SOFTWARE	TYR A:224 , PRO A:519 , ARG A:522 , HOH A:2178	BINDING SITE FOR RESIDUE CL A1627
4	AC4	SOFTWARE	HIS A:383 , HIS A:387 , GLU A:411 , 3ES A:1635	BINDING SITE FOR RESIDUE ZN A1628
5	AC5	SOFTWARE	ASP A:52 , ASP A:396 , LEU A:397 , PRO A:398 , ARG A:402 , BMA A:1633	BINDING SITE FOR RESIDUE EPE A1634
6	AC6	SOFTWARE	GLN A:281 , HIS A:353 , ALA A:354 , SER A:355 , ALA A:356 , GLU A:376 , VAL A:380 , HIS A:383 , GLU A:384 , HIS A:387 , PHE A:391 , HIS A:410 , GLU A:411 , PHE A:457 , LYS A:511 , PHE A:512 , HIS A:513 , VAL A:518 , TYR A:520 , TYR A:523 , PHE A:527 , ZN A:1628 , 3ES A:1636 , HOH A:2321 , HOH A:2323 , HOH A:2424 , HOH A:2425	BINDING SITE FOR RESIDUE 3ES A1635
7	AC7	SOFTWARE	TRP A:59 , TYR A:62 , ASN A:66 , GLU A:123 , ARG A:124 , TRP A:220 , MET A:223 , TRP A:357 , TYR A:360 , GLU A:403 , SER A:517 , PRO A:519 , ARG A:522 , 3ES A:1635 , HOH A:2089 , HOH A:2426 , HOH A:2427 , HOH A:2428 , HOH A:2429 , HOH A:2430	BINDING SITE FOR RESIDUE 3ES A1636
8	AC8	SOFTWARE	SER A:45 , GLU A:49 , ASN A:72 , THR A:74 , GLU A:76 , ASN A:109 , SER A:295 , ARG A:348 , EPE A:1634	BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 109 RESIDUES 1629 TO 1633

Asymmetric/Biological Unit

No.	Residues
1	A:152	-	A:158
2	A:352	-	A:370
3	A:538	-	A:550

Asymmetric/Biological Unit

No.	Residues
1	Glu A:162	-	Pro A:163

Asymmetric/Biological Unit (6, 6)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_034602	M	828	T	ACE_HUMAN	Polymorphism	13306091	A	M	223	T
2	UniProt	VAR_023432	T	916	M	ACE_HUMAN	Polymorphism	3730043	A	T	311	M
3	UniProt	VAR_014189	I	1018	T	ACE_HUMAN	Polymorphism	4976	A	I	413	T
4	UniProt	VAR_014190	F	1051	V	ACE_HUMAN	Polymorphism	4977	A	F	446	V
5	UniProt	VAR_023433	T	1187	M	ACE_HUMAN	Polymorphism	12709442	A	T	582	M
6	UniProt	VAR_023434	P	1228	L	ACE_HUMAN	Polymorphism	121912703	A	P	623	L

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ZINC_PROTEASE	PS00142	Neutral zinc metallopeptidases, zinc-binding region signature.	ACE_HUMAN	387-396 985-994	1	- A:380-389

Asymmetric/Biological Unit (12, 12)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000290866	1a	ENSE00001837678	chr17:61554432-61554704	273	ACE_HUMAN	1-83	83	0	-	-
1.2	ENST00000290866	2	ENSE00001730325	chr17:61555292-61555459	168	ACE_HUMAN	84-139	56	0	-	-
1.3	ENST00000290866	3	ENSE00001701763	chr17:61556368-61556461	94	ACE_HUMAN	140-171	32	0	-	-
1.4	ENST00000290866	4	ENSE00001645813	chr17:61557130-61557273	144	ACE_HUMAN	171-219	49	0	-	-
1.5	ENST00000290866	5	ENSE00001792699	chr17:61557698-61557889	192	ACE_HUMAN	219-283	65	0	-	-
1.6	ENST00000290866	6	ENSE00001692982	chr17:61558452-61558549	98	ACE_HUMAN	283-315	33	0	-	-
1.7	ENST00000290866	7	ENSE00001711922	chr17:61558927-61559099	173	ACE_HUMAN	316-373	58	0	-	-
1.8	ENST00000290866	8	ENSE00001761869	chr17:61559827-61560050	224	ACE_HUMAN	373-448	76	0	-	-
1.9	ENST00000290866	9	ENSE00001684602	chr17:61560390-61560534	145	ACE_HUMAN	448-496	49	0	-	-
1.10	ENST00000290866	10	ENSE00001799028	chr17:61560821-61560919	99	ACE_HUMAN	496-529	34	0	-	-
1.11	ENST00000290866	11	ENSE00001715718	chr17:61561210-61561332	123	ACE_HUMAN	529-570	42	0	-	-
1.12	ENST00000290866	12	ENSE00001741036	chr17:61561691-61561902	212	ACE_HUMAN	570-641	72	0	-	-
1.14	ENST00000290866	14	ENSE00001680947	chr17:61562597-61562733	137	ACE_HUMAN	641-686	46	1	A:40-81	42
1.15	ENST00000290866	15	ENSE00001763320	chr17:61563918-61564076	159	ACE_HUMAN	687-739	53	1	A:82-134	53
1.16	ENST00000290866	16	ENSE00001046871	chr17:61564347-61564434	88	ACE_HUMAN	740-769	30	1	A:135-164	30
1.17	ENST00000290866	17	ENSE00001046888	chr17:61566009-61566152	144	ACE_HUMAN	769-817	49	1	A:164-212	49
1.18	ENST00000290866	18	ENSE00001046881	chr17:61566302-61566493	192	ACE_HUMAN	817-881	65	1	A:212-276	65
1.19	ENST00000290866	19	ENSE00001046911	chr17:61568315-61568412	98	ACE_HUMAN	881-913	33	1	A:276-308	33
1.20	ENST00000290866	20	ENSE00001180835	chr17:61568570-61568742	173	ACE_HUMAN	914-971	58	1	A:309-366	58
1.21	ENST00000290866	21	ENSE00001180829	chr17:61570797-61571020	224	ACE_HUMAN	971-1046	76	1	A:366-441 (gaps)	76
1.22	ENST00000290866	22	ENSE00001046826	chr17:61571283-61571427	145	ACE_HUMAN	1046-1094	49	1	A:441-489	49
1.23	ENST00000290866	23	ENSE00001046886	chr17:61571733-61571831	99	ACE_HUMAN	1094-1127	34	1	A:489-522	34
1.24b	ENST00000290866	24b	ENSE00001180817	chr17:61573755-61573877	123	ACE_HUMAN	1127-1168	42	1	A:522-563	42
1.25	ENST00000290866	25	ENSE00001180815	chr17:61574159-61574346	188	ACE_HUMAN	1168-1231	64	1	A:563-624	62
1.26b	ENST00000290866	26b	ENSE00001944704	chr17:61574498-61574804	307	ACE_HUMAN	1231-1306	76	0	-	-

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:581
 aligned with ACE_HUMAN | P12821 from UniProtKB/Swiss-Prot  Length:1306

    Alignment length:585
                                   654       664       674       684       694       704       714       724       734       744       754       764       774       784       794       804       814       824       834       844       854       864       874       884       894       904       914       924       934       944       954       964       974       984       994      1004      1014      1024      1034      1044      1054      1064      1074      1084      1094      1104      1114      1124      1134      1144      1154      1164      1174      1184      1194      1204      1214      1224     
           ACE_HUMAN    645 DEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPN 1229
               SCOP domains d2xy9a_ A: Angiotensin converting enzyme, ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains Peptidase_M2-2xy9A01 A:40-623                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           - Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhheee.....eee..hhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhh...hhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.........ee...........hhhhhhhhh........hhhhhhhhh..hhhhhhhhhhhhhhhh.....hhhhhhhh...............eeee......eeee.....hhhhhhhhhhhhhhhhhhhhh...hhhhh...hhhhhhhhhhhhhhhhhhhhhhhhh....----hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhee.........hhhhhh........hhhhhhhhhhhhhhhhhhhhhh....hhhhh....hhhhhhhhhhhhh.....hhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh.............. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------T---------------------------------------------------------------------------------------M-----------------------------------------------------------------------------------------------------T--------------------------------V---------------------------------------------------------------------------------------------------------------------------------------M----------------------------------------L- SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ZINC_PROTE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.14  PDB: A:40-81 UniProt: 641-686  Exon 1.15  PDB: A:82-134 UniProt: 687-739            Exon 1.16  PDB: A:135-164     -----------------------------------------------Exon 1.18  PDB: A:212-276 UniProt: 817-881                       --------------------------------Exon 1.20  PDB: A:309-366 UniProt: 914-971                --------------------------------------------------------------------------Exon 1.22  PDB: A:441-489 UniProt: 1046-1094     --------------------------------Exon 1.24b  PDB: A:522-563                ------------------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------Exon 1.17  PDB: A:164-212 UniProt: 769-817       ---------------------------------------------------------------Exon 1.19  PDB: A:276-308        ---------------------------------------------------------Exon 1.21  PDB: A:366-441 (gaps) UniProt: 971-1046                          -----------------------------------------------Exon 1.23  PDB: A:489-522         ----------------------------------------Exon 1.25  PDB: A:563-624 UniProt: 1168-1231 [INCOMPLETE]      Transcript 1 (2)
                2xy9 A   40 DEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLS----SDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPA  624
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429    |  439       449       459       469       479       489       499       509       519       529       539       549       559       569       579       589       599       609       619     
                                                                                                                                                                                                                                                                                                                                                                                                                                    434  439

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a+b) (23004)

Fold: Zincin-like (701)

Superfamily: Metalloproteases (zincins), catalytic domain (647)

Family: Neurolysin-like (55)

Protein domain: Angiotensin converting enzyme, ACE (14)

Human (Homo sapiens) [TaxId: 9606] (11)

d2xy9a_

(no "CATH Domain" information available for 2XY9)

Asymmetric/Biological Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Peptidase_MA (251)

Family: Peptidase_M2 (20)

Homo sapiens (Human) (10)

Peptidase_M2-2xy9A01

A:40-623

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (ACE_HUMAN | P12821)

molecular function
	GO:0003779	actin binding	Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments.
	GO:0031711	bradykinin receptor binding	Interacting selectively and non-covalently with a bradykinin receptor.
	GO:0004180	carboxypeptidase activity	Catalysis of the hydrolysis of the terminal or penultimate peptide bond at the C-terminal end of a peptide or polypeptide.
	GO:0031404	chloride ion binding	Interacting selectively and non-covalently with chloride ions (Cl-).
	GO:0008144	drug binding	Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
	GO:0004175	endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
	GO:0008238	exopeptidase activity	Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain, in a reaction that requires a free N-terminal amino group, C-terminal carboxyl group or both.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0070573	metallodipeptidase activity	Catalysis of the hydrolysis of a dipeptide by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
	GO:0008237	metallopeptidase activity	Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
	GO:0051019	mitogen-activated protein kinase binding	Interacting selectively and non-covalently with a mitogen-activated protein kinase.
	GO:0031434	mitogen-activated protein kinase kinase binding	Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase, any protein that can phosphorylate a MAP kinase.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0008241	peptidyl-dipeptidase activity	Catalysis of the release of C-terminal dipeptides from a polypeptide chain.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0008240	tripeptidyl-peptidase activity	Catalysis of the release of an N-terminal tripeptide from a polypeptide.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0050435	amyloid-beta metabolic process	The chemical reactions and pathways involving amyloid-beta, a glycoprotein associated with Alzheimer's disease, and its precursor, amyloid precursor protein (APP).
	GO:0002005	angiotensin catabolic process in blood	The chemical reactions and pathways resulting in the breakdown of angiotensin in the blood.
	GO:0002003	angiotensin maturation	The process leading to the attainment of the full functional capacity of angiotensin by conversion of renin substrate into mature angiotensin in the blood.
	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
	GO:0050482	arachidonic acid secretion	The controlled release of arachidonic acid from a cell or a tissue.
	GO:0001974	blood vessel remodeling	The reorganization or renovation of existing blood vessels.
	GO:0071838	cell proliferation in bone marrow	The multiplication or reproduction of cells, resulting in the expansion of a cell population in the bone marrow.
	GO:0060047	heart contraction	The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
	GO:0060218	hematopoietic stem cell differentiation	The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
	GO:0042447	hormone catabolic process	The chemical reactions and pathways resulting in the breakdown of any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
	GO:0001822	kidney development	The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
	GO:0032943	mononuclear cell proliferation	The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.
	GO:1903597	negative regulation of gap junction assembly	Any process that stops, prevents or reduces the frequency, rate or extent of gap junction assembly.
	GO:0002446	neutrophil mediated immunity	Any process involved in the carrying out of an immune response by a neutrophil.
	GO:0043171	peptide catabolic process	The chemical reactions and pathways resulting in the breakdown of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
	GO:2000170	positive regulation of peptidyl-cysteine S-nitrosylation	Any process that activates or increases the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
	GO:1900086	positive regulation of peptidyl-tyrosine autophosphorylation	Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.
	GO:0061098	positive regulation of protein tyrosine kinase activity	Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0060177	regulation of angiotensin metabolic process	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving angiotensin.
	GO:0008217	regulation of blood pressure	Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
	GO:1902033	regulation of hematopoietic stem cell proliferation	Any process that modulates the frequency, rate or extent of hematopoietic stem cell proliferation.
	GO:0002019	regulation of renal output by angiotensin	The process in which angiotensin directly modulates the rate of urine output by the kidney.
	GO:0014910	regulation of smooth muscle cell migration	Any process that modulates the frequency, rate or extent of smooth muscle cell migration.
	GO:0003081	regulation of systemic arterial blood pressure by renin-angiotensin	The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system.
	GO:0019229	regulation of vasoconstriction	Any process that modulates the frequency, rate or extent of reductions in the diameter of blood vessels.
	GO:0007283	spermatogenesis	The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005768	endosome	A vacuole to which materials ingested by endocytosis are delivered.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005764	lysosome	A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		3ES	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ACT	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		CL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EPE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Glu A:162 - Pro A:163	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2xy9
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ACE_HUMAN \| P12821
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.4.15.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ACE_HUMAN \| P12821
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1o86	CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME IN COMPLEX WITH LISINOPRIL.
1o8a	CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME (NATIVE).
1uze	COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
1uzf	COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
2c6f	STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN
2c6n	STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN WITH LISINOPRIL
2iul	HUMAN TACE G13 MUTANT
2iux	HUMAN TACE MUTANT G1234
2xyd	HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (8, 12)

Sites (8, 8)

SS Bonds (3, 3)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (6, 6)

PROSITE Motifs (1, 1)

Exons (12, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (0, 0)

Pfam Domains (1, 1)

Gene Ontology (55, 55)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File